CompletedNot applicableNCT00615797
Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea
Studying Sydenham chorea
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Cape Town
- Principal Investigator
- Kathleen Walker, MB ChBRed Cross Children's Hospital, University of Cape Town
- Intervention
- Intravenous immunoglobulin(biological)
- Enrollment
- 20 target
- Eligibility
- 4-16 years · All sexes
- Timeline
- 2002 – 2009
Study locations (1)
- Red Cross Children's Hospital, Cape Town, Western Cape, South Africa
Collaborators
Natal Bioproducts Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00615797 on ClinicalTrials.gov